Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $66.2300 (2.89%) ($64.0300 - $66.2300) on Wed. Aug. 30, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.81% (three month average) | RSI | 34 | Latest Price | $66.2300(2.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -1.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(94%) XHB(76%) IVW(73%) IWO(69%) VFMO(69%) | Factors Impacting LGND price | LGND will decline at least -0.905% in a week (0% probabilities). VXX(-47%) UUP(-31%) TBT(-22%) XLU(-15%) VIXM(-13%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.905% (StdDev 1.81%) | Hourly BBV | 3.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $62.06(-6.3%) | Resistance Level | $66.71 | 5 Day Moving Average | $65.36(1.33%) | 10 Day Moving Average | $65.92(0.47%) | 20 Day Moving Average | $66.71(-0.72%) | To recent high | -16.2% | To recent low | 2.9% | Market Cap | $1.064b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |